Real-Life Clinical Efficacy of Acoramidis in Participants With ATTR-CM and Association With Cardiac Biomarkers

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(16 sites)

Japan

Research Site, Bunkyō City

Research Site, Kumamoto

Research Site, Kurume-shi

Research Site, Kyoto

Research Site, Mitaka-shi

Research Site, Nagoya

Research Site, Nankoku-shi

Research Site, Okayama

Research Site, Ōtsu

Research Site, Sagamihara-shi

Research Site, Sapporo

Research Site, Shinjuku-ku

Research Site, Suita-shi

Research Site, Tsu

Research Site, Yufu-shi